Abstract
This paper describes the development and validation of a HPLC method for the quantitation of Emtricitabine, Tenofovir, and Efavirenz in pure form and pharmaceutical formulations. The Zorbax SB CN, (250×4.6mm, 5μm) column was used. UV detection was performed at 260nm. The mobile phase consisted of methanol (A) and buffer at pH 4.5(B) using the gradient: 0–10min (90%B), 10–22min (35%B), and 22–25min (90%B). The flow rate was 1.5ml/min in ambient temperature. The injection volume of sample was 20μl. The method showed to be linear (r2>0.999), precise (RSD<0.76%), accurate (recovery of 100.09% for Emtricitabine, 99.88% for Tenofovir and 100.04% for Efavirenz), specific and robust. Three batches of Emtricitabine, Tenofovir, and Efavirenz tablets were assayed by the validated method. The Emtricitabine contents in the tablet samples varied from 99.94 to 101.60%. The Tenofovir content in the tablet samples varied from 99.13 to 101.81% while Efavirenz content varied from 100.01 to 101.67%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
